Oxyntomodulin analogs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9593155
APP PUB NO 20150307580A1
SERIAL NO

14686760

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Peptide analogs of oxyntomodulin (OXM, glucagon-37), which have been modified to be resistant to cleavage and inactivation by dipeptidyl peptidase IV (DPP-IV) and to increase in vivo half-life of the peptide analog while enabling the peptide analog to act as a dual GLP-1/glucagon receptor (GCGR) agonist are described. The peptide analogs are useful for treatment of metabolic disorders such as diabetes and obesity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME CORPRAHWAY NJ 07065

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bianchi, Elisabetta Pommezia, IT 54 263
Capito, Elena Pommezia, IT 3 5
Carrington, Paul E Rahway, US 8 6
Dimarchi, Richard Indianapolis, US 16 411
Eiermann, George J Rahway, US 3 65
Ingallinella, Paolo Pommezia, IT 12 139
Marsh, Donald J Rahway, US 14 183
Metzger, Joseph M Rahway, US 12 52
Pessi, Antonello Pommezia, IT 44 280
Pocai, Alessandro Rahway, US 5 19
Santoprete, Alessia Pommezia, IT 9 42
Sinha, Roy Ranabir Rahway, US 3 65
Ward, Brian Bloomington, US 52 807

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 14, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00